Article Text
Abstract
Background: The neuroactive steroid 3α, 5α-tetrahydroprogesterone is the most potent endogenous positive modulator of γ-amino-butyric acid (GABA)A receptors. There is evidence for a relation between neuroactive steroids and seizure susceptibility.
Objective: To evaluate the putative role of counteregulator neuroactive steroids in the occurrence of seizures in patients with tuberous sclerosis.
Methods: Plasma concentrations of the enantiomers 3α, 5α- and 3α, 5β-tetrahydroprogesterone (3αs-THP), which are positive modulators of GABAA receptors, were measured in 18 patients, along with their endogenous functional antagonists 3β, 5α- and 3β, 5β-THP (3βs-THP), to assess their possible modification compared with control subjects. Neuroactive steroids were assayed using a highly sensitive and specific gas chromatographic/mass spectrometric method.
Results: In the tuberous sclerosis patients with poorly controlled seizures, there was a significantly lower 3αs/3βs-THP ratio than in seizure-free patients or control subjects.
Conclusions: The reduced 3αs/3βs-THP ratio may decrease GABAergic tone, contributing to the appearance of seizures in tuberous sclerosis patients with epilepsy.
- tetrahydroprogesterone
- epilepsy
- neuroactive steroids
- tuberous sclerosis
- GABA
- γ-amino-butyric acid
- 3αs-THP, 3α, 5α- and 3α, 5β-tetrahydroprogesterone
- 3βs-THP
- 3β
- 5α- and 3β
- 5β-THP (functional antagonists of 3αs-THP
Statistics from Altmetric.com
Footnotes
-
Competing interests: none declared